20 May 2013
Keywords: glaxo, wellcome, may, provide, relenza, free, uk
Article | 13 October 1999
The furore that greeted the UK's recently-created National Institute forClinical Excellence's recommendation that Glaxo Wellcome's new influenza drug, the neuraminidase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.